SCIEX, a global leader in life science analytical technologies, today announced that it has acquired the mass spectrometry business of Labindia Instruments Pvt. Ltd., a leading life science solutions service provider in India. This acquisition represents SCIEX's increasing investment in India, combining its global resources, world-class scientific expertise and product development leadership with well-established, local expertise and on-site support to advance science and respond to the growing needs of India's scientific community.
Labindia's mass spectrometry business has been serving Indian users of SCIEX instrumentation for the past 15 years. The transition of this business, including customer relationships, personnel and application support facilities, to SCIEX is a direct result of the successful track record that SCIEX and Labindia have had as partners in India. SCIEX's expansion of its commercial operations in India is expected to create new opportunities for customer interactions, collaborations and innovation.
SCIEX has a more than 20-year history of innovation and is a market leader in mass spectrometry, which is a workhorse analytical technique for a wide variety of scientific applications, including food contamination testing, environmental analysis, biomedical research, drug discovery and development, forensic toxicology and vitamin D analysis, among other emerging applications in clinical research.
The company has been actively involved in applying the power of mass spectrometry to assist in efforts to protect the health and safety of India's vast population. SCIEX announced last year, for instance, that through its distribution relationship with Labindia, it supplied a food safety testing solution to six major laboratories under the pesticides monitoring network project by India's government. This was part of a project with the Ministry of Agriculture to help reinforce new food safety standards through better monitoring for contamination.
"Expansion of SCIEX's commercial operations in India will strengthen our position and help us build on the success of Labindia's mass spectrometry business as well as execute on our growth strategy," said Umesh Pawa, Managing Director, SCIEX India. "By integrating Indian sales, service and support functions into SCIEX's global resources and operational excellence, we will simplify the process for customers to do business with SCIEX and drive the highest standard of support, further enhancing customer satisfaction levels. We will now be able to engage in a new level of dialogue with Indian scientists, who are among the leaders pushing the limits to improve life in this region."
SCIEX and Labindia are working closely to ensure a smooth transition of Labindia's former mass spectrometry-focused personnel, who will provide uninterrupted service and support during this changeover and continue to be the day-to-day contacts for Indian mass spectrometry customers. As part of SCIEX, the team will continue to work from their current locations in India.